Association of sleep time with diabetes mellitus and impaired glucose tolerance.

BACKGROUND Experimental sleep restriction causes impaired glucose tolerance (IGT); however, little is known about the metabolic effects of habitual sleep restriction. We assessed the cross-sectional relation of usual sleep time to diabetes mellitus (DM) and IGT among participants in the Sleep Heart Health Study, a community-based prospective study of the cardiovascular consequences of sleep-disordered breathing. METHODS Participants were 722 men and 764 women, aged 53 to 93 years. Usual sleep time was obtained by standardized questionnaire. Diabetes mellitus was defined as a serum glucose level of 126 mg/dL or more (> or =7.0 mmol/L) fasting or 200 mg/dL or more (> or =11.1 mmol/L) 2 hours following standard oral glucose challenge or medication use for DM. Impaired glucose tolerance was defined as a 2-hour postchallenge glucose level of 140 mg/dL or more (> or =7.8 mmol/L) and less than 200 mg/dL. The relation of sleep time to DM and IGT was examined using categorical logistic regression with adjustment for age, sex, race, body habitus, and apnea-hypopnea index. RESULTS The median sleep time was 7 hours per night, with 27.1% of subjects sleeping 6 hours or less per night. Compared with those sleeping 7 to 8 hours per night, subjects sleeping 5 hours or less and 6 hours per night had adjusted odds ratios for DM of 2.51 (95% confidence interval, 1.57-4.02) and 1.66 (95% confidence interval, 1.15-2.39), respectively. Adjusted odds ratios for IGT were 1.33 (95% confidence interval, 0.83-2.15) and 1.58 (95% confidence interval, 1.15-2.18), respectively. Subjects sleeping 9 hours or more per night also had increased odds ratios for DM and IGT. These associations persisted when subjects with insomnia symptoms were excluded. CONCLUSIONS A sleep duration of 6 hours or less or 9 hours or more is associated with increased prevalence of DM and IGT. Because this effect was present in subjects without insomnia, voluntary sleep restriction may contribute to the large public health burden of DM.

[1]  Atul Malhotra,et al.  A prospective study of sleep duration and coronary heart disease in women. , 2003, Archives of internal medicine.

[2]  J. Seyer,et al.  Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor-alpha and TNF-alpha fragments. , 1992, The American journal of physiology.

[3]  E. F. Colecchia,et al.  Adaptation of the 24-h growth hormone profile to a state of sleep debt. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[4]  J. Samet,et al.  The Sleep Heart Health Study: design, rationale, and methods. , 1997, Sleep.

[5]  J. Manson,et al.  A prospective study of self-reported sleep duration and incident diabetes in women. , 2003, Diabetes care.

[6]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[7]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[8]  Gregor Hasler,et al.  The association between short sleep duration and obesity in young adults: a 13-year prospective study. , 2004, Sleep.

[9]  K. Spiegel,et al.  Impact of sleep debt on metabolic and endocrine function , 1999, The Lancet.

[10]  D. Kripke,et al.  Mortality associated with sleep duration and insomnia. , 2002, Archives of general psychiatry.

[11]  Bonnie K. Lind,et al.  Methods for obtaining and analyzing unattended polysomnography data for a multicenter study. Sleep Heart Health Research Group. , 1998, Sleep.

[12]  J. Edinger,et al.  The distribution and clinical significance of sleep time misperceptions among insomniacs. , 1995, Sleep.

[13]  K. Lam,et al.  Obstructive sleep apnea is independently associated with insulin resistance. , 2002, American journal of respiratory and critical care medicine.

[14]  M. Irwin,et al.  Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: clinical implications. , 1999, The Journal of clinical endocrinology and metabolism.

[15]  L. Breslow,et al.  The relationship between vitamin C intake, general health practices, and mortality in Alameda County, California. , 1986, American journal of public health.

[16]  J. Després,et al.  Health consequences of visceral obesity , 2001, Annals of medicine.

[17]  N. Istfan,et al.  Effects of systemic infusions of endotoxin, tumor necrosis factor, and interleukin-1 on glucose metabolism in the rat: relationship to endogenous glucose production and peripheral tissue glucose uptake. , 1994, Metabolism: clinical and experimental.

[18]  E. C. Hammond,et al.  SOME PRELIMINARY FINDINGS ON PHYSICAL COMPLAINTS FROM A PROSPECTIVE STUDY OF 1,064,004 MEN AND WOMEN. , 1964, American journal of public health and the nation's health.

[19]  E. C. Hammond,et al.  Coronary heart disease, stroke, and aortic aneurysm. , 1969, Archives of environmental health.

[20]  E. Rüther,et al.  Interactions between evening and nocturnal cortisol secretion and sleep parameters in patients with severe chronic primary insomnia , 2002, Neuroscience Letters.

[21]  L. Berkman,et al.  A multivariate analysis of health-related practices: a nine-year mortality follow-up of the Alameda County Study. , 1982, American journal of epidemiology.

[22]  E. Bixler,et al.  Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. , 2001, The Journal of clinical endocrinology and metabolism.

[23]  J. Larson.  The MOS 36-Item Short form Health Survey , 1997, Evaluation & the health professions.

[24]  Rainer Rauramaa,et al.  Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. , 2002, Diabetes care.

[25]  K. Spiegel,et al.  Impact of a sleep length on the 24-hour leptin profile , 2001 .

[26]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[27]  B. Wajchenberg.  Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. , 2000, Endocrine reviews.

[28]  Denise L. Smith,et al.  Effects of short-term inactivity on glucose tolerance, energy expenditure, and blood flow in trained subjects. , 1998, Journal of applied physiology.

[29]  P. Savage,et al.  Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group. , 1992, Journal of clinical epidemiology.

[30]  V. Large,et al.  Sex differences in visceral fat lipolysis and metabolic complications of obesity. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[31]  J. Seyer,et al.  Interleukin 1α and an interleukin 1β fragment are somnogenic , 1990 .

[32]  J. Sorkin,et al.  Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. , 2002, American journal of respiratory and critical care medicine.

[33]  K. Clark,et al.  Association of Sleep-Disordered Breathing, Sleep Apnea, and Hypertension in a Large Community- Based Study , 2000 .

[34]  S. Kira,et al.  Daily walking reduces visceral adipose tissue areas and improves insulin resistance in Japanese obese subjects. , 2002, Diabetes research and clinical practice.

[35]  E. van Cauter,et al.  Sleep loss results in an elevation of cortisol levels the next evening. , 1997, Sleep.

[36]  D. Skene,et al.  Comparison between subjective and actigraphic measurement of sleep and sleep rhythms , 1999, Journal of sleep research.

[37]  A Tremblay,et al.  Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. , 1994, The American journal of cardiology.